Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

Overview of attention for article published in Annals of Internal Medicine, March 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news: 11 news outlets
blogs: 1 blog
twitter: 16 X users

facebook: 1 Facebook page
bluesky: 1 Bluesky user
podcasts: 1 podcast

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 11 news stories from 11 outlets.

Cessation of aspirin in older adults not associated with adverse health effects | 2 Minute Medicine

2 Minute Medicine , 30 Mar 2022

1. Aspirin cessation in older adults led to increased cardiovascular disease events, though not statistically significant.

Questions Remain About Safety of Aspirin Cessation in Older Adults

Clinical Advisor, 16 Mar 2022

HealthDay News — A subgroup analysis of the ASPREE trial could not conclusively demonstrate clear harm or benefit of either…

Questions remain about safety of aspirin cessation in older adults

MedicalXpress, 15 Mar 2022

A subgroup analysis of the ASPREE trial could not conclusively demonstrate clear harm or benefit of either cessation or…

Questions Remain About Safety of Aspirin Cessation in Older Adults

MPR, 15 Mar 2022

HealthDay News — A subgroup analysis of the ASPREE trial could not conclusively demonstrate clear harm or benefit of either…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 7 additional news stories.